Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
DarioHealth Corp (DRIO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/27/2025: DRIO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -71.52% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/27/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 24.53M USD | Price to earnings Ratio - | 1Y Target Price 2.33 |
Price to earnings Ratio - | 1Y Target Price 2.33 | ||
Volume (30-day avg) 348033 | Beta 1.42 | 52 Weeks Range 0.56 - 1.93 | Updated Date 04/1/2025 |
52 Weeks Range 0.56 - 1.93 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.61 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-03-26 | When Before Market | Estimate -0.2267 | Actual -0.0433 |
Profitability
Profit Margin -158.09% | Operating Margin (TTM) -143.86% |
Management Effectiveness
Return on Assets (TTM) -33.11% | Return on Equity (TTM) -65.68% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 27178327 | Price to Sales(TTM) 0.91 |
Enterprise Value 27178327 | Price to Sales(TTM) 0.91 | ||
Enterprise Value to Revenue 1.01 | Enterprise Value to EBITDA -0.59 | Shares Outstanding 41567000 | Shares Floating 33591553 |
Shares Outstanding 41567000 | Shares Floating 33591553 | ||
Percent Insiders 21.28 | Percent Institutions 20.2 |
Analyst Ratings
Rating 5 | Target Price 3.5 | Buy - | Strong Buy 3 |
Buy - | Strong Buy 3 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
DarioHealth Corp
Company Overview
History and Background
DarioHealth Corp. was founded in 2011. Initially focused on diabetes management, it has evolved into a digital health company offering solutions for chronic conditions including diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. It went public through a reverse merger in 2014.
Core Business Areas
- Chronic Condition Management: Provides a comprehensive digital health platform for managing multiple chronic conditions, integrating connected devices, data analytics, and personalized coaching.
- B2B Solutions: Partners with employers, health plans, and providers to offer its platform as a benefits solution for their members and employees.
Leadership and Structure
The CEO is Erez Raphael. The company has a structured management team including CFO, CTO, and Chief Medical Officer. Board of Directors oversees the company's strategic direction.
Top Products and Market Share
Key Offerings
- Dario Blood Glucose Monitoring System: A smart glucose meter and mobile app that tracks blood glucose levels. Market share information is difficult to ascertain precisely; however, competitors include Ascensia Diabetes Care (Contour), Abbott (Freestyle Libre), and Dexcom (continuous glucose monitoring).
- Dario Hypertension Management: A connected blood pressure monitor and app that allows individuals to track and manage their blood pressure. Competitors include Omron, Withings, and iHealth.
- Dario Weight Management: Provides personalized weight management plans, including meal planning, coaching, and connected scale. Competitors include Weight Watchers (WW), Noom, and Calibrate.
Market Dynamics
Industry Overview
The digital health market is experiencing significant growth, driven by increasing prevalence of chronic diseases, rising healthcare costs, and advancements in technology. The industry is fragmented with many players focusing on specific niches.
Positioning
DarioHealth Corp. positions itself as a comprehensive digital health platform for managing multiple chronic conditions, differentiating itself from single-condition solutions.
Total Addressable Market (TAM)
The global digital health market is projected to reach hundreds of billions of dollars in the coming years. DarioHealth Corp. is targeting a significant portion of this market by expanding its offerings and partnerships.
Upturn SWOT Analysis
Strengths
- Comprehensive multi-condition platform
- Integration of connected devices and data analytics
- Partnerships with employers and health plans
- Personalized coaching and support
Weaknesses
- Relatively small market share compared to established players
- High marketing and sales expenses
- Dependence on partnerships for distribution
- Need to demonstrate long-term clinical and economic outcomes
Opportunities
- Expanding partnerships with employers and health plans
- Acquiring new technologies and capabilities
- Entering new markets
- Increasing adoption of digital health solutions
Threats
- Competition from established players
- Changing regulatory landscape
- Data security and privacy concerns
- Reimbursement challenges
Competitors and Market Share
Key Competitors
- LVGO
- TDOC
- OMH
- CVS
- AMZN
Competitive Landscape
DarioHealth Corp. faces intense competition from larger and more established players. Its competitive advantage lies in its comprehensive multi-condition platform and personalized approach.
Major Acquisitions
WayForward
- Year: 2021
- Acquisition Price (USD millions): 30
- Strategic Rationale: Expanded behavioral health capabilities and broadened platform.
Upright
- Year: 2021
- Acquisition Price (USD millions): 58
- Strategic Rationale: Added musculoskeletal (MSK) care to the Dario platform, enhancing its offerings.
Growth Trajectory and Initiatives
Historical Growth: Revenue growth has been driven by increasing adoption of its platform and partnerships.
Future Projections: Future growth is expected to be driven by further expansion of its platform, partnerships, and market share.
Recent Initiatives: Recent initiatives include expanding its platform to new conditions, acquiring new technologies, and strengthening its partnerships.
Summary
DarioHealth Corp. is a growing digital health company with a comprehensive platform and strategic partnerships. Its revenue is growing, but profitability remains a challenge. The company needs to effectively manage its expenses and demonstrate long-term value to succeed against larger competitors and navigate the changing digital health landscape.
Similar Companies
- LVGO
- TDOC
- OMH
- CVS
- AMZN
- DXCM
- ABT
- MTD
Sources and Disclaimers
Data Sources:
- Company Filings (SEC), Investor Presentations, Industry Reports, Third-Party Market Research
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Market share data is approximate and may vary based on source.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About DarioHealth Corp
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2014-10-06 | CEO & Director Mr. Erez Raphael | ||
Sector Healthcare | Industry Health Information Services | Full time employees 196 | Website https://www.dariohealth.com |
Full time employees 196 | Website https://www.dariohealth.com | ||
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.